Article
Clinical Neurology
Mira Salih, Mohmed M. M. Salem, Justin M. M. Moore, Christopher S. S. Ogilvy
Summary: This study aimed to explore the most cost-effective screening strategy for female smokers. The findings suggest that screening female smokers for unruptured intracranial aneurysm is cost-effective, with screening at a younger age bringing more health benefits at a lower cost, while frequent screening leads to higher costs per quality-adjusted life year.
Article
Clinical Neurology
Tim Yannick Cras, Myriam M. G. Hunink, Ruben Dammers, Adriaan C. G. M. van Es, Victor Volovici, James F. Burke, Femke C. C. Kremers, Diederik W. J. Dippel, Bob Roozenbeek
Summary: This study aimed to determine the optimal MRI surveillance strategies for the growth of UIAs using cost-effectiveness analysis and develop a clinical tool for personalizing UIA surveillance. The results showed that the optimal surveillance strategy varied in different countries, and it is feasible to personalize the surveillance strategy considering factors such as age and aneurysm characteristics.
Article
Oncology
Lindy M. Kregting, Valerie D. V. Sankatsing, Eveline A. M. Heijnsdijk, Harry J. de Koning, Nicolien T. van Ravesteyn
Summary: This study evaluates the cost-effectiveness of breast cancer screening strategies in the Netherlands and finds that switching from biennial to triennial screening, with a lower starting age of 44, can increase benefits at lower costs.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Cardiac & Cardiovascular Systems
Clara Marquina, Paul Lacaze, Jane Tiller, Moeen Riaz, Amy C. Sturm, Mark R. Nelson, Brian A. Ference, Jing Pang, Gerald F. Watts, Stephen J. Nicholls, Sophia Zoungas, Danny Liew, John McNeil, Zanfina Ademi
Summary: Population genomic screening for heterozygous familial hypercholesterolemia (FH) in all young adults in Australia is cost-effective and can lead to longer and healthier lives by preventing coronary heart disease.
EUROPEAN HEART JOURNAL
(2022)
Correction
Clinical Neurology
Tim Yannick Cras, Myriam M. G. Hunink, Ruben Dammers, C. G. M. van Adriaan, Victor Volovici, James F. Burke, Femke C. C. Kremers, Diederik W. J. Dippel, Bob Roozenbeek
Summary: In the Research Article Surveillance of Unruptured Intracranial Aneurysms: Cost-Effectiveness Analysis for 3 Countries by Cras et al.,(1), the author byline was published with an incorrect order. The correct author order is as follows
Article
Medicine, General & Internal
Jigang Chen, Mingyang Han, Xin Feng, Fei Peng, Xin Tong, Hao Niu, Danfeng Zhang, Aihua Liu
Summary: The study aimed to evaluate different screening and follow-up strategies for intracranial aneurysms among patients with BAV, and concluded that screening every 10 years with biennial follow-up was the optimal strategy from the Chinese healthcare payer's perspective.
Review
Clinical Neurology
Gabriel J. E. Rinkel, Ynte M. Ruigrok
Summary: This review discusses high-risk groups who may benefit from screening for unruptured intracranial aneurysms to prevent aneurysmal subarachnoid hemorrhage. It outlines the advantages and disadvantages of screening, as well as the importance of counseling. Additional research is needed to identify more high-risk groups and improve the efficiency of screening.
INTERNATIONAL JOURNAL OF STROKE
(2022)
Article
Health Care Sciences & Services
Matthew Jones, Ralph K. Akyea, Katherine Payne, Steve E. Humphries, Hasidah Abdul-Hamid, Stephen Weng, Nadeem Qureshi
Summary: This study determines the cost-effectiveness of six case-finding strategies for screening of electronic health records to identify index patients who have genetically confirmed monogenic FH in English primary care. FAMCAT2 was found to be the most cost-effective screening approach.
JOURNAL OF PERSONALIZED MEDICINE
(2022)
Article
Public, Environmental & Occupational Health
Haonan Li, Hui Zhang
Summary: This study used cost-effectiveness analysis to optimize COVID-19 screening strategies under China's dynamic zero-case policy. Nine screening strategies with different screening frequencies and combinations of detection methods were designed. A stochastic agent-based model simulated the progress of the COVID-19 outbreak in two scenarios. The results showed that high-frequency screening is cost-effective and can help contain the spread of the epidemic under China's COVID-19 dynamic zero-case policy. Mass antigen testing is not cost-effective compared to mass nucleic acid testing, and using AT as a supplemental screening tool is more cost-effective when NAT capacity is insufficient or when outbreaks are spreading rapidly.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Gastroenterology & Hepatology
Faisal S. Ali, Tomas DaVee, Elmer Bernstam, Lillian S. Kao, Mike Wandling, Maryam R. Hussain, Shahrooz Rashtak, Srinivas Ramireddy, Sushovan Guha, Nirav Thosani
Summary: This study evaluates the cost-effectiveness of diagnostic modalities for patients with cholelithiasis and intermediate probability for choledocholithiasis (IPC). The findings suggest that laparoscopic cholecystectomy with intraoperative cholangiogram (LC-IOC) is the most cost-effective strategy, limiting preoperative testing and shortening hospital LOS.
GASTROINTESTINAL ENDOSCOPY
(2022)
Article
Clinical Neurology
Clark A. Veet, Stephen Capone, David Panczykowski, Natasha Parekh, Kenneth J. Smith, Dong H. Kim, H. Alex Choi, Spiros L. Blackburn
Summary: The study found that immediate surgical treatment is the most cost-effective strategy for small unruptured anterior circulation aneurysms, particularly in patients under 70 years of age. The cost-effectiveness of immediate surgery is highly sensitive to factors such as diagnosis age, rupture rate, and surgical complication risk.
CEREBROVASCULAR DISEASES
(2022)
Article
Multidisciplinary Sciences
E. Hachem, P. Meliga, A. Goetz, P. Jeken Rico, J. Viquerat, A. Larcher, R. Valette, A. F. Sanches, V. Lannelongue, H. Ghraieb, R. Nemer, Y. Ozpeynirci, T. Liebig
Summary: This study aims to identify and characterize novel flow-deviator stent devices through a high-fidelity computational framework and deep reinforcement learning algorithms. The goal is to enable patient-specific treatment by accurately adjusting the functional parameters in the implanted state.
SCIENTIFIC REPORTS
(2023)
Article
Medicine, General & Internal
John T. Schousboe, Brian L. Sprague, Linn Abraham, Ellen S. O'Meara, Tracy Onega, Shailesh Advani, Louise M. Henderson, Karen J. Wernli, Dongyu Zhang, Diana L. Miglioretti, Dejana Braithwaite, Karla Kerlikowske
Summary: The study found that extending screening mammography to age 80 may have benefits for some women, but the absolute reduction in death rates is small for women with comorbidities. Therefore, women over 75 should weigh the risks and benefits when considering screening mammography.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Medicine, General & Internal
John T. Schousboe, Brian L. Sprague, Linn Abraham, Ellen S. O'Meara, Tracy Onega, Shailesh Advani, Louise M. Henderson, Karen J. Wernli, Dongyu Zhang, Diana L. Miglioretti, Dejana Braithwaite, Karla Kerlikowske
Summary: Extending mammography screening to age 80 appears to be cost-effective in certain scenarios, but the absolute number of deaths averted is small, especially for women with comorbidities. Women considering screening beyond age 75 should carefully weigh the potential harms of overdiagnosis against the potential benefits of averting breast cancer death.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Clinical Neurology
Isabel C. Hostettler, Benjamin O'Callaghan, Enrico Bugiardini, Emer O'Connor, Jana Vandrovcova, Indran Davagnanam, Varinder Alg, Stephen Bonner, Daniel Walsh, Diederik Bulters, Neil Kitchen, Martin M. Brown, Joan Grieve, David J. Werring, Henry Houlden
Summary: The study reveals the significance of ANGPTL6 gene variants in familial intracranial aneurysms, indicating a potential role in abnormal blood vessel proliferation. Screening familial IA cases for ANGPTL6 and related genes is emphasized, along with highlighting the ANGPTL6 pathway as a potential therapeutic target.
Article
Health Care Sciences & Services
Kevin Jenniskens, Ghizelda R. Lagerweij, Christiana A. Naaktgeboren, Lotty Hooft, Karel G. M. Moons, Judith M. Poldervaart, Hendrik Koffijberg, Johannes B. Reitsma
JOURNAL OF CLINICAL EPIDEMIOLOGY
(2019)
Article
Endocrinology & Metabolism
Cindy Meun, Marlise N. Gunning, Yvonne Louwers, Henrike Peters, Jolien Roos-Hesselink, Jeanine Roeters van Lennep, Oscar-Leonel Rueda Ochoa, Yolande Appelman, Nils Lambalk, Eric Boersma, Maryam Kavousi, Bart C. J. M. Fauser, Joop S. E. Laven, Sara Baart, Laura Benschop, Laura Brouwers, Ricardo Budde, Suzanne Cannegieter, Veerle Dam, Rene Eijkemans, Bart Fauser, Michel Ferrari, Arie Franx, Christianne de Groot, Marlise Gunning, Annemieke Hoek, Erik Koffijberg, Wendy Koster, Mark Kruit, Giske Lagerweij, Joop Laven, Katie Linstra, Aad van der Lugt, Angela Maas, Antoinette Maassen van den Brink, Saskia Middeldorp, Karel G. M. Moons, Bas van Rijn, Luuk Scheres, Yvonne T. van der Schouw, Eric Steegers, Regine Steegers, Gisela Terwindt, Birgitta Velthuis, Marieke Wermer, Bart Zick, Gerbrand Zoet
CLINICAL ENDOCRINOLOGY
(2020)
Correction
Pediatrics
Maarten O. Blanken, Geert W. Frederix, Wendy J. Ungar, Elisabeth E. Nibbelke, Hendrik Koffijberg, Elisabeth A. M. Sanders, Maroeska M. Rovers, Louis Bont
EUROPEAN JOURNAL OF PEDIATRICS
(2020)
Article
Cardiac & Cardiovascular Systems
J. J. Brugts, J. F. Veenis, S. P. Radhoe, G. C. M. Linssen, M. van Gent, C. J. W. Borleffs, J. van Ramshorst, P. van Pol, R. Tukkie, R. F. Spee, M. E. Emans, W. Kok, V van Halm, L. Handoko, S. L. M. A. Beeres, M. C. Post, E. Boersma, M. J. Lenzen, C. Manintveld, H. Koffijberg, P. van Baal, M. Versteegh, T. D. Smilde, L. van Heerebeek, M. Rienstra, A. Mosterd, P. P. H. Delnoy, F. W. Asselbergs, H. P. Brunner-La Rocca, R. A. de Boer
NETHERLANDS HEART JOURNAL
(2020)
Article
Cardiac & Cardiovascular Systems
G. R. Lagerweij, L. Brouwers, G. A. De Wit, K. G. M. Moons, L. Benschop, A. H. E. M. Maas, A. Franx, M. J. H. Wermer, J. E. Roeters van Lennep, B. B. van Rijn, H. Koffijberg, Y. Appelman, S. Baart, L. Benschop, E. Boersma, L. Brouwers, R. P. J. Budde, S. C. Cannegieter, V. Dam, R. Eijkemans, B. C. J. M. Fauser, M. D. Ferrari, A. Franx, C. J. M. de Groot, M. N. Gunning, A. Hoek, H. Koffijberg, M. P. H. Koster, M. C. Kruit, G. R. Lagerweij, C. B. Lambalk, J. S. E. Laven, K. M. Linstra, A. van der Lugt, A. H. E. M. Maas, A. Maassen van den Brink, C. Meun, S. Middeldorp, K. G. M. Moons, B. B. van Rijn, J. E. Roeters van Lennep, J. W. Roos-Hesselink, L. J. J. Scheres, Y. T. van der Schouw, E. A. P. Steegers, R. P. M. Steegers-Theunissen, G. M. Terwindt, B. K. Velthuis, M. J. H. Wermer, B. Zick, G. A. Zoet
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
(2020)
Review
Economics
Koen Degeling, Martin Vu, Hendrik Koffijberg, Hui-Li Wong, Miriam Koopman, Peter Gibbs, Maarten IJzerman
Article
Economics
Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro, Suzanne Kosmider, Rachel Wong, Belinda Lee, Matthew Burge, Jeanne Tie, Desmond Yip, Louise Nott, Adnan Khattak, Stephanie Lim, Susan Caird, Peter Gibbs, Maarten IJzerman
Article
Pathology
Michiel van de Ven, Hendrik Koffijberg, Valesca Retel, Kim Monkhorst, Egbert Smit, Wim van Harten, Maarten IJzerman
Summary: The study found significant variations in biomarker testing among patients with stage IV nonesmall-cell lung cancer, with different biomarker tests having different costs. Most common biomarkers were assessed in the initial tests, while emerging biomarkers were tested later in the testing sequence.
JOURNAL OF MOLECULAR DIAGNOSTICS
(2021)
Article
Oncology
Sherin A. Said, Reini W. Bretveld, Hendrik Koffijberg, Gabe S. Sonke, Roy F. P. M. Kruitwagen, Joanne A. de Hullu, Anne M. van Altena, Sabine Siesling, Maaike A. van der Aa
Summary: This study aimed to identify clinicopathologic factors predictive of early relapse in advanced epithelial ovarian cancer (EOC) in first-line treatment, and to develop and internally validate risk prediction models. Results showed factors influencing early relapse included disease stage, histologic subtype, and presence of ascites. The pretreatment model had subpar performance, while the postoperative model based on age, stage, CA-125 level, subtype, ascites, treatment approach, and residual disease showed adequate performance.
CANCER EPIDEMIOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Carina M. Behr, Hendrik Koffijberg, Koen Degeling, Rozemarijn Vliegenthart, Maarten J. IJzerman
Summary: The study estimated the maximum acceptable cost per screened individual for low-dose computed tomography (LDCT) lung cancer screening and evaluated the impact of additionally screening for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), or both. The results showed that combined screening for lung cancer and cardiovascular disease is more economically viable than screening for lung cancer alone, primarily due to the benefits of cardiovascular disease screening. Screening high-risk populations for cardiovascular disease is more cost-effective compared to COPD.
EUROPEAN RADIOLOGY
(2022)
Article
Rheumatology
Ria Wolkorte, Lieke Heesink, Michelle M. A. Kip, Hendrik Koffijberg, Monique Tabak, Christiane Gruenloh
Summary: Most rheumatoid arthritis (RA) patients feel they have sufficient insight into their disease and perceive added value in using the HandScan monitoring device, mainly due to the additional knowledge it provides on inflammation. Patients believe that using an optical spectral transmission device can increase their understanding of their current disease status and support discussions with rheumatologists on treatment options.
RHEUMATOLOGY INTERNATIONAL
(2022)
Article
Health Care Sciences & Services
Deon Lingervelder, Hendrik Koffijberg, Jon D. Emery, Paul Fennessy, Christopher P. Price, Harm van Marwijk, Torunn B. Eide, Sverre Sandberg, Jochen W. L. Cals, Joke T. M. Derksen, Ron Kusters, Maarten J. IJzerman
Summary: The study found that countries with low POCT uptake face challenges of ineffective communication between various organizations involved in POCT, as well as high workload for general practitioners implementing POCT. Countries with a single national authority responsible for POCT have better uptake as they can govern the task effectively and reduce workload for GPs.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
(2021)
Article
Health Care Sciences & Services
Michiel van de Ven, Maarten IJzerman, Valesca Retel, Wim van Harten, Hendrik Koffijberg
Summary: This study demonstrates the application of dynamic simulation modeling in analyzing the nationwide implementation of Whole Genome Sequencing (WGS) for non-small cell lung cancer (NSCLC). The results show that the organization of the diagnostic pathway and referral patterns significantly impact the duration of the diagnostic process when implementing WGS.
BMC MEDICAL RESEARCH METHODOLOGY
(2022)
Review
Economics
Martijn J. Oude J. Wolcherink, Carina M. M. Behr, Xavier G. L. V. Pouwels, Carine J. M. Doggen, Hendrik Koffijberg
Summary: This study systematically reviewed the cost effectiveness of recent early detection strategies for cardiovascular disease (CVD) in at-risk adult populations. The findings suggest that most early detection strategies are cost effective and can reduce CVD-related costs. However, the lack of standardization complicates the comparison of cost-effectiveness outcomes between studies.
Article
Primary Health Care
Jorn S. S. Heerink, Ruud Oudega, Rogier Hopstaken, Hendrik Koffijberg, Ron Kusters
Summary: Clinical judgement in primary care is often decisive, and the use of Clinical decision rules (CDRs) is limited in this setting. This paper discusses the implementation barriers and the need for tailor-made CDRs in primary care. The case study on the Oudega rule highlights the importance of evaluating current CDRs and anticipating new developments for improved patient-oriented care.
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT
(2023)